Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Coughing; exhausted; Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a female patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. In OCT-2024, the patient received RSV vaccine. In OCT-2024, 2 days after receiving RSV vaccine, the patient experienced sickness (Verbatim: Sick). On an unknown date, the patient experienced cough (Verbatim: Coughing) and exhaustion (Verbatim: exhausted). The outcome of the sickness, cough and exhaustion were not reported. It was unknown if the reporter considered the sickness, cough and exhaustion to be related to RSV vaccine. It was unknown if the company considered the sickness, cough and exhaustion to be related to RSV vaccine. Additional Information: GSK Receipt Date: 14-APR-2025 This case was reported by a patient's husband via interactive digital media. The patient and reporter got the RSV shot in October and 2 days later they got very sick. The patient and the reporter were coughing, sick and exhausted for more than 6 months. This case is linked with case US2025AMR046636, reported by the same reporter.; Sender's Comments: US-GSK-US2025AMR046636:Same reporter